Author: Xiaomin Luo; Wei Zhou; Xiaojie Yan; Tangxi Guo; Benchao Wang; Hongxia Xia; Lu Ye; Jun Xiong; Zongping Jiang; Yu Liu; Bicheng Zhang; Weize Yang
Title: Prognostic value of C-reactive protein in patients with COVID-19 Document date: 2020_3_23
ID: m76ic66s_27
Snippet: In conclusion, our results suggested that admission serum CRP level performed well in discriminating disease severity and predicting adverse outcome in patients with COVID-19. Patients with markedly elevated admission CRP should be provided more attention and strengthened treatment. The findings from this single-center study need to be validated by multi-center research with larger samples......
Document: In conclusion, our results suggested that admission serum CRP level performed well in discriminating disease severity and predicting adverse outcome in patients with COVID-19. Patients with markedly elevated admission CRP should be provided more attention and strengthened treatment. The findings from this single-center study need to be validated by multi-center research with larger samples.
Search related documents:
Co phrase search for related documents- admission serum and crp level: 1, 2, 3, 4, 5, 6, 7, 8, 9
- admission serum and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
- admission serum and single center: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- admission serum and single center study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- admission serum crp level and adverse outcome: 1
- admission serum crp level and crp level: 1, 2, 3, 4, 5, 6, 7
- admission serum crp level and disease severity: 1, 2
- admission serum crp level and single center: 1
- admission serum crp level and single center study: 1
- adverse outcome and crp level: 1, 2, 3, 4
- adverse outcome and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
- adverse outcome and large sample: 1, 2
- adverse outcome and patient adverse outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- adverse outcome and single center: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- adverse outcome and single center study: 1, 2, 3, 4, 5, 6, 7, 8, 9
- attention provide and disease severity: 1, 2
- attention provide and large sample: 1
- crp level and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
- crp level and single center: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
Co phrase search for related documents, hyperlinks ordered by date